TodayNews for Health Professionals FDA Approves TNKase (tenecteplase) for the Treatment of Acute Ischemic Stroke in Adults South San Francisco, CA -- March 3, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug......
The latest pharma patient news and updates covering the pharma patient journey, engagement, and support.
A heartwarming review of cardiovascular news, most-loved stories This week on "The Top Line," we celebrate Valentine's Day with a discussion about heart-related updates and the stories we've loved covering in 2025. ByAndrea Park,Gabrielle MassonFeb 14, 2025 09:00am ...
A heartwarming review of cardiovascular news, most-loved stories This week on "The Top Line," we celebrate Valentine's Day with a discussion about heart-related updates and the stories we've loved covering in 2025. By Andrea Park, Gabrielle MassonFeb 14, 2025 09:00am Pharma BMS’ Opdual...
INDUSTRY UPDATES press releasesRead more... Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab) Celltrion today announced that the European Commission EC has granted marketing authorization for Avtozma CTP a biosimilar referencing RoActemra tocilizumab Av...
Sign up for Packaging Digest newsletters SUBSCRIBE TODAY Our Network PlasticsTodayMD+DIQmed+Design NewsPowder & Bulk SolidsBattery Technology Events MD&M Packaging EastMD&M Packaging MidwestMD&M Packaging SouthPACKEX TorontoPACKEX MontrealSustainable Manufacturing Expo/WestPackMore Informa Markets Engineering Event...
Today, we offer state-of-the art technologies, full product support and regulatory services that fulfill the need for preservative-free multi-dose systems worldwide. FIND OUT MORE Bag-on-Valve Aptar Pharma’s Bag-On-Valve (BOV) technology is clean, convenient and cost effective technology that...
South San Francisco, CA -- February 12, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi®... FDA Approves Gomekli (mirdametinib...
Aug 7, 2024 | News STAMFORD, Conn., August 7, 2024 – Purdue Pharma L.P. (“Purdue”) announced today that the U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the Zurnai™ (nalmefene injection) Auto-Injector. Zurnai (zur nye) is a single...
The Pharma Data is an Information-Centric Website focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences